Jinbo Yu
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Nephrology top 5%
- Dialysis and Renal Disease Management
Papers in
-
- Cardiac Arrhythmias and Treatments 10
- Atrial Fibrillation Management and Outcomes 7
- Heart Failure Treatment and Management 3
-
- Dialysis and Renal Disease Management 5
- Co-authors
- Li‐Bin Pan (6 shared papers)Ran Peng (6 shared papers)Shurong Ma (6 shared papers)Zhenxiong Zhao (5 shared papers)Jian‐Dong Jiang (4 shared papers)Zhenlin Zhang (12 shared papers)Wen‐Zhen Fu (12 shared papers)Jie‐Mei Gu (11 shared papers)
- Journals
- Frontiers in Cardiovascular Medicine (5 papers)Acta Pharmacologica Sinica (4 papers)BMC Cardiovascular Disorders (2 papers)Blood Purification (2 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Jinbo Yu
60 papers receiving 1.4k citations
Jinbo Yu's Hit Papers
Peers
Comparison fields: 5 of 120
- Biological Psychiatry 103
- Nephrology 108
- Cardiology and Cardiovascular Medicine 251
- Pharmacology 89
- Pharmacology 119
Countries citing papers authored by Jinbo Yu
This map shows the geographic impact of Jinbo Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinbo Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinbo Yu more than expected).
Fields of papers citing papers by Jinbo Yu
This network shows the impact of papers produced by Jinbo Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinbo Yu. The network helps show where Jinbo Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jinbo Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota Hit paper breakdown → | 2021 | 253 |
| 2 | Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota Hit paper breakdown → | 2022 | 131 |
| 3 | 2018 | 109 | |
| 4 | 2019 | 81 | |
| 5 | 2010 | 62 | |
| 6 | 2011 | 61 | |
| 7 | 2009 | 59 | |
| 8 | 2013 | 57 | |
| 9 | 2018 | 47 | |
| 10 | 2008 | 40 | |
| 11 | 2009 | 37 | |
| 12 | 2020 | 28 | |
| 13 | 2009 | 25 | |
| 14 | 2019 | 25 | |
| 15 | 2014 | 24 | |
| 16 | 2015 | 23 | |
| 17 | 2021 | 21 | |
| 18 | 1998 | 21 | |
| 19 | 2016 | 20 | |
| 20 | 2023 | 20 |
About Jinbo Yu
Jinbo Yu is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology, Molecular Biology, Orthopedics and Sports Medicine and Surgery, having authored 65 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cardiac Arrhythmias and Treatments (10 papers), Atrial Fibrillation Management and Outcomes (7 papers), Dialysis and Renal Disease Management (5 papers), Gut microbiota and health (4 papers), Bone health and osteoporosis research (4 papers), Berberine and alkaloids research (3 papers), Heart Failure Treatment and Management (3 papers) and Tryptophan and brain disorders (3 papers). The work is most often cited by research in Biological Psychiatry (103 citations), Nephrology (108 citations), Cardiology and Cardiovascular Medicine (251 citations), Pharmacology (89 citations) and Pharmacology (119 citations). Jinbo Yu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Li‐Bin Pan, Ran Peng, Shurong Ma, Zhenxiong Zhao, Jian‐Dong Jiang, Zhenlin Zhang, Wen‐Zhen Fu, Jie‐Mei Gu, Jin‐Wei He and Qian Tong. Their work appears in journals such as Frontiers in Cardiovascular Medicine, Acta Pharmacologica Sinica, BMC Cardiovascular Disorders, Blood Purification and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.